Upcoming event

Tags

Show all

Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade

European Urology, Volume 75, Issue 2, February 2019, Pages 221-228

Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial

European Urology, November 2018

Effect on survival of ADT alone compared to ADT combined with concurrent RT to the prostate in patients with primary bone metastatic PCa in a prospective randomised clinical trial: data from the HORRAD trial

European Urology, September 2018

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

The Lancet Journal, Volume 392, Issue 10162, October 2018, Pages 2353-2366

A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG

European Urology, October 2018

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imagingtargeted and Systematic Biopsies

European Urology, October 2018

Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial

Lancet Oncol., Volume 19, Issue 10, September 2018, Pages 1404-1416

Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies

Am J Clin Nutr., Volume 101, Issue 1, January 2015, Pages 87-117

The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells

J Urol. , Volume 193, Issue 2, February 2015, Pages 690-698

Novel actions of next-generation taxanes benefit advanced stages of prostate cancer

Clin Cancer Res. 2015 Feb 15, Volume 21, Issue 4, Pages 795-807

Extent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further pT3 subclassification

Urology, Volume 85, Issue 1, January 2015, Pages 161-164

UK single centre experience of rare and atypical variant of castrate-resistant prostate cancer: Poorly differentiated neuroendocrine small-cell carcinoma

Journal of Clinical Urology, Volume 8, Pages 19-29

Next